Lyell Immunopharma, Inc.
LYEL • NASDAQ
Lyell Immunopharma, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Lynn Seely, with a market cap of $556.4M.
Market Cap$556.4M
Employees224.0
CEOLynn Seely
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
Lyell Immunopharma, Inc. FAQ
Common questions about Lyell Immunopharma, Inc.
Lyell Immunopharma, Inc. is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $4.0K.
Lyell Immunopharma, Inc. has approximately 224 employees.